脑部放疗，上午比下午敏感许多！
7 e, M" K0 A' y# H: ^. F7 u# D( p }! P3 R, i5 S/ B* E4 V
2 ^! c! Q" J' E7 ]2 iCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.6 e* c6 T: z% p! R2 V4 |8 p7 W. w8 b0 q
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
) L9 \0 @& ~9 J# ?6 O7 [Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T., f( U; U% J- h( O7 W
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
6 E) S4 J! L" H+ Y, z8 {" s7 [8 L! ^1 U, U. B
Abstract7 d- s5 n! l1 Y
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.0 F) t- m- e/ u, U0 P5 d
$ v' @" S6 Z2 L. I$ e
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
4 A& |/ ^3 j! d& i# f2 m
+ C) l; _* G* C2 ^RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
( P, P* s4 `( g ]
7 e* _: H2 q& YCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.5 l* S; S1 a" r
$ Y4 W$ @9 Z' S9 i |
3 O9 X7 V% @' V2 l* v$ @' a9 e
显身卡
